Eyetech Pharmaceuticals Company
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.
Technology:
Geroscience
Industry:
Biopharma, Biotechnology, Medical
Headquarters:
New York, New York, United States
Founded Date:
1-1
Funding Status:
M&A
Investors Number:
1
Last Funding Type:
Non-equity Assistance
Register and Claim Ownership